Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

NCT01772771 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT01772771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01772771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2012
Completion date
March 1, 2033
Enrollment
12,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma, hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm, melanoma, sarcoma